Praxis Precision Medicines Inc. PRAX
Super Investor & Insider
1
Fondi che lo detengono
#1212
Rank consenso
1.4%
% dei portafogli
$3.2M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Polen Capital Management · Polen Capital Management | 0.02% | Buy | 10,043 | $3.2M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Praxis Precision Medicines Inc. operates within the biopharmaceutical sector, focusing on the development of treatments for central nervous system (CNS) disorders. The company's primary objective is to address unmet medical needs by leveraging their extensive research in genetics, the neurobiology of CNS disorders, and…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees168
TickerPRAX
Statistics
Market Cap$7.58B
Revenue (TTM)$0
Net Income-$303.3M
Net Margin—
EPS$-13.48
P/E-19.54
P/S—
P/B4.90
EV/EBITDA-16.58
ROE-35.3%
Dividend Yield—
Price$271.98
Data: Twelve Data · Revenue = mcap / P/S